JP2006521379A5 - - Google Patents

Download PDF

Info

Publication number
JP2006521379A5
JP2006521379A5 JP2006508796A JP2006508796A JP2006521379A5 JP 2006521379 A5 JP2006521379 A5 JP 2006521379A5 JP 2006508796 A JP2006508796 A JP 2006508796A JP 2006508796 A JP2006508796 A JP 2006508796A JP 2006521379 A5 JP2006521379 A5 JP 2006521379A5
Authority
JP
Japan
Prior art keywords
group
alkyl
alkoxy
halogen
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006508796A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006521379A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/005235 external-priority patent/WO2004094382A1/en
Publication of JP2006521379A publication Critical patent/JP2006521379A/ja
Publication of JP2006521379A5 publication Critical patent/JP2006521379A5/ja
Pending legal-status Critical Current

Links

JP2006508796A 2003-03-21 2004-03-12 ムスカリン性アゴニスト Pending JP2006521379A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45691303P 2003-03-21 2003-03-21
PCT/US2004/005235 WO2004094382A1 (en) 2003-03-21 2004-03-12 Muscarinic agonists

Publications (2)

Publication Number Publication Date
JP2006521379A JP2006521379A (ja) 2006-09-21
JP2006521379A5 true JP2006521379A5 (enExample) 2007-04-12

Family

ID=33310664

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006508796A Pending JP2006521379A (ja) 2003-03-21 2004-03-12 ムスカリン性アゴニスト

Country Status (5)

Country Link
US (1) US20060154922A1 (enExample)
EP (1) EP1608619A1 (enExample)
JP (1) JP2006521379A (enExample)
CA (1) CA2518324A1 (enExample)
WO (1) WO2004094382A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2880885B1 (fr) * 2005-01-14 2009-01-30 Merck Sante Soc Par Actions Si Derives d'acide phenylbenzoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
AU2012243329B2 (en) 2011-04-13 2015-09-17 Merck Sharp & Dohme Corp. 5-substituted iminothiazines and their mono-and dioxides as BACE inhibitors,compositions,and their use
CN103596939A (zh) * 2011-04-13 2014-02-19 默沙东公司 作为bace抑制剂的5-取代的亚氨基噻嗪类及其单和二氧化物、组合物及其应用
WO2014113893A1 (en) * 2013-01-28 2014-07-31 University Of Manitoba Use of galantamine and related compounds for treatment of inflammatory bowel diseases
US10149477B2 (en) 2014-10-06 2018-12-11 Basf Se Substituted pyrimidinium compounds for combating animal pests
BR112019025191B1 (pt) 2017-06-19 2023-11-28 Basf Se Compostos de pirimidínio substituídos, composição, método para proteger culturas, semente revestida, uso dos compostos e uso de um composto
US20230031024A1 (en) 2018-12-18 2023-02-02 Basf Se Substituted pyrimidinium compounds for combating animal pests
CN109942576B (zh) * 2019-03-07 2020-09-11 上海工程技术大学 Irbinitinib及中间体的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0874625B1 (en) * 1996-01-22 2005-03-16 Eli Lilly And Company Indane derivatives for antipsychotic compositions
CA2297906A1 (en) * 1997-07-22 1999-02-04 Bret Eugene Huff Pharmaceutical compounds

Similar Documents

Publication Publication Date Title
JP2007520440A5 (enExample)
JP2017533968A5 (enExample)
JP2009515988A5 (enExample)
JP2014051526A5 (enExample)
JP2011515398A5 (enExample)
JP2008525417A5 (enExample)
JP2009536620A5 (enExample)
JP2010535722A5 (enExample)
JP2013510178A5 (enExample)
JP2002030084A5 (enExample)
JP2018511587A5 (enExample)
JP2006502119A5 (enExample)
JPWO2020017587A5 (enExample)
JP2013509392A5 (enExample)
JP2007518822A5 (enExample)
JP2017509689A5 (enExample)
JP2013533253A5 (enExample)
JP2017517538A5 (enExample)
JP2005538111A5 (enExample)
RU2009103300A (ru) Производные 2-бензоилимидазопиридинов, их получение и их применение в терапии
JP2005527542A5 (enExample)
JP2006508979A5 (enExample)
JP2020530848A5 (enExample)
JP2006523698A5 (enExample)
JP2004507527A5 (enExample)